Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cencora, Inc.

NYSE: COR · Trade & Services · 7 alerts · CIK 1140859

Share price
$356.94Close, Nov 16
Market cap
$68.1B
Shares outstanding
190.83MLatest SEC cover page
Sector
Trade & Services
Industry
Wholesale-Drugs, Proprietaries & Druggists' SundriesSIC 5122

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cencora, Inc. filings on SEC EDGAR ↗

9:26 AM ET 8-K
Business Update

Cencora Business Update

Cencora, Inc. announced a reorganization of its operating model and reporting structure to advance growth priorities and improve visibility. Beginning in fiscal 2027, the company will report results across three segments: Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other. The filing includes supplemental unaudited historical segment data for fiscal 2025 and 2026 recast under this new structure to assist investor analysis.

6:38 AM ET 8-K
Financial Results

Cencora Financial Results

Cencora reported fiscal year 2026 revenue of $337.4 billion, up 5.0% year-over-year, and adjusted diluted EPS of $17.97. The company introduced a new operating model and reportable segments following its acquisition of OneOncology and provided fiscal 2027 adjusted EPS guidance of $19.40 to $19.75.

Term
FY2026

“Fiscal 2026 was a pivotal year for Cencora, as we expanded our MSO platform through the acquisition of OneOncology, sharpened the focus of our portfolio and delivered record results.”

Robert P. Mauch, President and Chief Executive Officer of Cencora

“As we enter fiscal 2027, our new operating model is designed to strengthen our execution and provide visibility to our progress.”

Robert P. Mauch, President and Chief Executive Officer of Cencora
4:07 PM ET Form 4
Insider Selling

Cencora SVP & CAO Lazarus Krikorian Sells $326K of Stock

Lazarus Krikorian, SVP & CAO, sold 986 shares of Cencora, Inc. at $330.96 a share, worth $326K in total on Nov 2, 2026. Shares held after the trade: 14,197 (-6.5%).

Value
$326K
Shares
986
Price
$330.96
Role
SVP & CAO
Holding change
-6.5%
Trade date
Nov 2, 2026
7:49 AM ET 8-K
M&A Deal

Cencora Signs $2.4B M&A Deal with American Oncology Network, Inc.

Cencora has signed a definitive agreement to acquire American Oncology Network (AON) for an enterprise value of $2.4 billion, including $2.3 billion at closing and up to $100 million in contingent value rights. The acquisition expands Cencora's oncology management services organization (MSO) platform by adding a network of over 350 oncology providers across 21 states.

Value
$2.4B
Counterparty
American Oncology Network, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.